跳至主要内容
临床试验/NL-OMON55081
NL-OMON55081已完成不适用

Isolation and immune profiling of human B lymphocytes for the development of potential diagnostic and therapeutic antibodies - AMELIA

niversitair Medisch Centrum Groningen0 个研究点目标入组 67 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
67

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 64(—)

入选标准

  • Female participants who are at least 18 years of age on the day of signing
  • informed consent with histologically confirmed primary diagnosis of uterine
  • cancer who are intended to be treated with hysterectomy will be enrolled in
  • this study.
  • The participant (or legally acceptable representative if applicable) provides
  • written informed consent for the trial.

排除标准

  • History of an autoimmune disease, specifically hepatitis A virus (HAV),
  • hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency
  • virus (HIV), or any other systemic intercurrent disease or condition that might
  • affect the immunocompetence of the patient, or treatment with systemic highly
  • immunosuppressive therapy (e.g. transplant recipients or patients who underwent
  • a splenectomy)
  • Use of systemic continuous corticosteroid therapy (e.g. prednisone i.v. or
  • p.o. >7.5 mg / day).
  • History of a second malignancy except for curatively treated low-stage tumors
  • with a histology that can be differentiated from UC.

研究者

相似试验